Improving germline genetic testing and genetic counseling referral in prostate, pancreatic, and colorectal cancer through a multidisciplinary quality improvement intervention.
580 Background: Germline testing (GLT) identifies hereditary cancer syndromes and informs precision oncology care. NCCN guidelines recommend genetic evaluation for all patients with pancreatic cancer (Panc), those with high-risk or metastatic prostate cancer (PCa), and select patients with colorectal cancer (CR...